Andreas Hoffmann
Business graduate (FH)
Auditor
Partner
Born in 1974
Focus areas
- Comprehensive transaction advice on the buyer and seller side for financial and strategic investors
- Implementation of financial and tax due diligences (red flag, full scope, vendor)
- Structuring advice
- Economic and tax advice during the negotiation of purchase agreements
- Preparation of financial fact books
- Financial modeling (preparation of business plans)
- Carrying out company valuations
Personal career
- Since 2011: Responsible partner, auditor and managing director in the Advisory division of BPG with a focus on transaction advice and due diligence
- 2006 – 2011: Authorized signatory in the Advisory division of BPG
- 2006: Appointed as auditor
- 2003 – 2006: Assistant in the Advisory division of BPG
- 2002: Consultant in the Valuation & Strategy division at PricewaterhouseCoopers
- 1998 – 2002: European Business Program at the University of Applied Sciences Münster and the Hogeschool Rotterdam
- 1995 – 1998: Training as a bank clerk
Language
- German
- English
- Dutch
Personal interests
- Tennis
- Jogging
- Soccer
- Skiing
Carpe Diem – Seize the day, but do it right!
Article by Andreas Hoffmann
Crowe BPG advises PINOVA on its investment in KIST + ESCHERICH GmbH
Funds advised by PINOVA Capital GmbH (“PINOVA”) have acquired a stake in KIST + ESCHERICH GmbH (“KIST + ESCHERICH”), which is headquartered in Munich and Dresden.
Continue reading article
Crowe advises the shareholders of HOMMEL PHARMA on the sale of their shares in VITAIRA
Crowe advised a shareholder of Hommel Pharma GmbH & Co. KG, a pharmaceutical and healthcare services provider (“HOMMEL PHARMA”) based in Dülmen (North Rhine-Westphalia), on the sale of its shares to the VITAIRA Group, an investor in European pharmaceutical logistics companies.
Continue reading article
Crowe advises 1Q Health on the acquisition of a majority stake in the EHF Group
Crowe advised the 1Q Health Group (“1Q Health”), a portfolio company of NORD Holding in the CDMO sector for dietary supplements and pharmaceuticals, on its acquisition of the EHF Group (“EHF”), a Dutch developer and manufacturer of dietary supplements.
Continue reading article
Cookie-Settings